{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:25:11Z","timestamp":1785324311127,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.nec.2024.11.008","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T07:38:42Z","timestamp":1738741122000},"page":"207-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnostic and Prognostic Biomarkers of Idiopathic Normal Pressure Hydrocephalus in Cerebrospinal Fluid and Blood"],"prefix":"10.1016","volume":"36","author":[{"given":"Aida","family":"Kamalian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Masoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Foroughmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Moghekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.nec.2024.11.008_bib1","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.0b013e31828c2fda","article-title":"Idiopathic normal-pressure hydrocephalus pathophysiology and diagnosis by CSF biomarkers","volume":"80","author":"Jeppsson","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nec.2024.11.008_bib2","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208037","article-title":"Prevalence of possible idiopathic normal pressure hydrocephalus in Sweden","volume":"102","author":"Constantinescu","year":"2024","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nec.2024.11.008_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217705","article-title":"Prevalence of idiopathic normal pressure hydrocephalus: a prospective, population-based study","volume":"14","author":"Andersson","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.nec.2024.11.008_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2176\/nmc.st.2020-0292","article-title":"Guidelines for management of idiopathic normal pressure hydrocephalus (third edition): endorsed by the Japanese Society of normal pressure hydrocephalus","volume":"61","author":"Nakajima","year":"2021","journal-title":"Neurol Med -Chir"},{"key":"10.1016\/j.nec.2024.11.008_bib5","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1227\/01.NEU.0000168185.29659.C5","article-title":"Diagnosing idiopathic normal-pressure hydrocephalus","volume":"57","author":"Relkin","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nec.2024.11.008_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2147\/CIA.S360736","article-title":"A\u00a0comparison of cerebrospinal fluid beta-amyloid and tau in idiopathic normal pressure hydrocephalus and neurodegenerative dementias","volume":"17","author":"Said","year":"2022","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.nec.2024.11.008_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbrc.2022.11.091","article-title":"A\u00a0pilot study assessing sphingolipids and glycolipids dysmetabolism in idiopathic normal pressure hydrocephalus","volume":"639","author":"Mutoh","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/j.nec.2024.11.008_bib8","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.neurobiolaging.2011.02.023","article-title":"A\u00a0unique N-glycan on human transferrin in CSF: a possible biomarker for iNPH","volume":"33","author":"Futakawa","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12987-016-0037-y","article-title":"Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus","volume":"13","author":"Jeppsson","year":"2016","journal-title":"Fluids Barriers CNS"},{"issue":"8","key":"10.1016\/j.nec.2024.11.008_bib10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00701-006-0787-4","article-title":"Analysis of potential diagnostic biomarkers in cerebrospinal fluid of idiopathic normal pressure hydrocephalus by proteomics","volume":"148","author":"Li","year":"2006","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.nec.2024.11.008_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577407","article-title":"AQP4 autoantibodies in patients with idiopathic normal pressure hydrocephalus","volume":"349","author":"Gastaldi","year":"2020","journal-title":"J\u00a0Neuroimmunol"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66154-y","article-title":"Association between cerebrospinal fluid biomarkers and age-related brain changes in patients with normal pressure hydrocephalus","volume":"10","author":"Taghdiri","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-023-00475-8","article-title":"Association between ventricular CSF biomarkers and outcome after shunt surgery in idiopathic normal pressure hydrocephalus","volume":"20","author":"Gr\u00f8nning","year":"2023","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.nec.2024.11.008_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1468-1331.2006.01593.x","article-title":"Cerebrospinal fluid tau, phospho-tau181 and \u03b2-amyloid1\u221242 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer\u2019s disease","volume":"14","author":"Kapaki","year":"2007","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.nec.2024.11.008_bib15","first-page":"989","article-title":"Change of amyloid-\u03b2 1-42 toxic conformer ratio after cerebrospinal fluid diversion predicts long-term cognitive outcome in patients with idiopathic normal pressure hydrocephalus","volume":"63","author":"Akiba","year":"2018","journal-title":"J\u00a0Alzheim Dis"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-018-0119-x","article-title":"Comparative analysis of cerebrospinal fluid metabolites in Alzheimer\u2019s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort","volume":"6","author":"Nagata","year":"2018","journal-title":"Biomark Res"},{"issue":"10","key":"10.1016\/j.nec.2024.11.008_bib17","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/jnnp-2019-320826","article-title":"CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics","volume":"90","author":"Jeppsson","year":"2019","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.nec.2024.11.008_bib18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jpsychires.2010.07.011","article-title":"Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (A\u03b2) peptide and phospho-tau","volume":"45","author":"Ray","year":"2011","journal-title":"J\u00a0Psychiatr Res"},{"issue":"7","key":"10.1016\/j.nec.2024.11.008_bib19","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.3390\/ijms24076084","article-title":"Brain-derived major glycoproteins are possible biomarkers for altered metabolism of cerebrospinal fluid in neurological diseases","volume":"24","author":"Hoshi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5\u20136","key":"10.1016\/j.nec.2024.11.008_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000514052","article-title":"Cerebrospinal fluid alzheimer\u2019s biomarkers and neurofilament light profile of idiopathic normal pressure hydrocephalus in China: a PUMCH cohort study","volume":"20","author":"Mao","year":"2020","journal-title":"Neurodegener Dis"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-170186","article-title":"Cerebrospinal fluid amyloid-\u03b2 42, total tau and phosphorylated tau are low in patients with normal pressure hydrocephalus: analogies and differences with alzheimer\u2019s disease","volume":"60","author":"Santangelo","year":"2017","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib22","first-page":"179","article-title":"Cerebrospinal fluid amyloid-\u03b2 oligomer levels in patients with idiopathic normal pressure hydrocephalus","volume":"83","author":"Kawamura","year":"2021","journal-title":"J\u00a0Alzheim Dis"},{"issue":"3","key":"10.1016\/j.nec.2024.11.008_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091974","article-title":"Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus","volume":"9","author":"Pyykk\u00f6","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.nec.2024.11.008_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jns.2015.07.001","article-title":"Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus","volume":"357","author":"Nakajima","year":"2015","journal-title":"J\u00a0Neurol Sci"},{"issue":"2","key":"10.1016\/j.nec.2024.11.008_bib25","first-page":"727","article-title":"Cerebrospinal fluid diagnostics of alzheimer\u2019s disease in patients with idiopathic normal pressure hydrocephalus","volume":"94","author":"Vanninen","year":"2023","journal-title":"J\u00a0Alzheim Dis"},{"issue":"3","key":"10.1016\/j.nec.2024.11.008_bib26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3233\/JAD-190119","article-title":"Cerebrospinal fluid level of aquaporin4: a new window on glymphatic system involvement in neurodegenerative disease?","volume":"69","author":"Arighi","year":"2019","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.nec.2024.11.008_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3988\/jcn.2019.15.3.353","article-title":"Cerebrospinal fluid levels of \u03b2-amyloid 40 and \u03b2-Amyloid 42 are proportionately decreased in amyloid positron-emission tomography negative idiopathic normal-pressure hydrocephalus patients","volume":"15","author":"Kim","year":"2019","journal-title":"J\u00a0Clin Neurol"},{"key":"10.1016\/j.nec.2024.11.008_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clineuro.2016.04.025","article-title":"Cerebrospinal fluid levels of tumor necrosis factor alpha and aquaporin 1 in patients with mild cognitive impairment and idiopathic normal pressure hydrocephalus","volume":"146","author":"Casta\u00f1eyra-Ruiz","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib29","first-page":"145","article-title":"Use of cerebrospinal fluid amyloid-\u03b2 and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus: clinical article","volume":"115","author":"Tarnaris","year":"2011","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JAD-190775","article-title":"Two-point dynamic observation of alzheimer\u2019s disease cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus","volume":"72","author":"Jingami","year":"2019","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"9","key":"10.1016\/j.nec.2024.11.008_bib31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/metabo11090616","article-title":"Transferrin biosynthesized in the brain is a novel biomarker for alzheimer\u2019s disease","volume":"11","author":"Hoshi","year":"2021","journal-title":"Metabolites"},{"issue":"12","key":"10.1016\/j.nec.2024.11.008_bib32","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00701-017-3314-x","article-title":"The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus","volume":"159","author":"Craven","year":"2017","journal-title":"Acta Neurochir"},{"issue":"4","key":"10.1016\/j.nec.2024.11.008_bib33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3233\/JAD-150268","article-title":"The expression of transthyretin and amyloid-\u03b2 protein precursor is altered in the brain of idiopathic normal pressure hydrocephalus patients","volume":"48","author":"Laiter\u00e4","year":"2015","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"7","key":"10.1016\/j.nec.2024.11.008_bib34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/1567205016666190725150836","article-title":"The CSF p-tau181\/A\u03b242 ratio offers a good accuracy \u201cin\u00a0vivo\u201d in the differential diagnosis of alzheimer\u2019s dementia","volume":"16","author":"Santangelo","year":"2019","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.nec.2024.11.008_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jsbmb.2015.05.004","article-title":"Steroid hormones in prediction of normal pressure hydrocephalus","volume":"152","author":"Sosvorova","year":"2015","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"3","key":"10.1016\/j.nec.2024.11.008_bib36","first-page":"168","article-title":"Somatostatin cerebrospinal fluid levels in dementia","volume":"238","author":"Molins","year":"1991","journal-title":"J\u00a0Neurol"},{"issue":"2","key":"10.1016\/j.nec.2024.11.008_bib37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1468-1331.2012.03781.x","article-title":"Soluble amyloid precursor protein \u03b1 in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus","volume":"20","author":"Miyajima","year":"2013","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.nec.2024.11.008_bib38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ghir.2015.10.001","article-title":"Serum IGF-1 is higher in patients with idiopathic normal pressure hydrocephalus than in the population","volume":"25","author":"Yang","year":"2015","journal-title":"Growth Horm IGF Res"},{"issue":"15","key":"10.1016\/j.nec.2024.11.008_bib39","doi-asserted-by":"crossref","first-page":"8034","DOI":"10.3390\/ijms22158034","article-title":"Novel insight in idiopathic normal pressure hydrocephalus (Inph) biomarker discovery in csf","volume":"22","author":"Torretta","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31756-0","article-title":"Particular CSF sphingolipid patterns identify iNPH and AD patients","volume":"8","author":"Torretta","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.nec.2024.11.008_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16179","article-title":"Peripheral immunity changes are associated with neurodegeneration and worse clinical outcome in idiopathic normal pressure hydrocephalus","volume":"31","author":"Bissacco","year":"2024","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.nec.2024.11.008_bib42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jb\/mvy043","article-title":"Rapid increase of \u201cbrain-type\u201d transferrin in cerebrospinal fluid after shunt surgery for idiopathic normal pressure hydrocephalus: a prognosis marker for cognitive recovery","volume":"164","author":"Murakami","year":"2018","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.nec.2024.11.008_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1117675","article-title":"White matter hyperintensity mediating gait disorders in iNPH patients via neurofilament light chain","volume":"15","author":"Yang","year":"2023","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"10.1016\/j.nec.2024.11.008_bib44","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/brainsci12111450","article-title":"Ventriculoperitoneal shunt treatment increases 7 Alpha Hy-Droxy-3-Oxo-4-Cholestenoic acid and 24-hydroxycholesterol concentrations in idiopathic normal pressure hydrocephalus","volume":"12","author":"Porru","year":"2022","journal-title":"Brain Sci"},{"issue":"3","key":"10.1016\/j.nec.2024.11.008_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1468-1331.2006.01553.x","article-title":"Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus","volume":"14","author":"Tullberg","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nec.2024.11.008_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2018.01.017","article-title":"Preoperative biomarkers in patients with idiopathic normal pressure hydrocephalus showing a favorable shunt surgery outcome","volume":"387","author":"Hong","year":"2018","journal-title":"J\u00a0Neurol Sci"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-180557","article-title":"Preoperative phosphorylated tau concentration in the cerebrospinal fluid can predict cognitive function three years after shunt surgery in patients with idiopathic normal pressure hydrocephalus","volume":"66","author":"Nakajima","year":"2018","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.nec.2024.11.008_bib48","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/ene.14575","article-title":"Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus","volume":"28","author":"Nakajima","year":"2021","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/01616412.2020.1831300","article-title":"P-Tau as prognostic marker in long term follow up for patients with shunted iNPH","volume":"43","author":"Migliorati","year":"2021","journal-title":"Neurol Res"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-2008-14102","article-title":"Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia","volume":"14","author":"Gloeckner","year":"2008","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.nec.2024.11.008_bib51","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JAD-181012","article-title":"Revisiting the cerebrospinal fluid biomarker profile in idiopathic normal pressure hydrocephalus: the bologna pro-hydro study","volume":"68","author":"Abu-Rumeileh","year":"2019","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.nec.2024.11.008_bib52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1600-0404.2007.00890.x","article-title":"CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus","volume":"116","author":"\u00c5gren-Wilsson","year":"2007","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"10.1016\/j.nec.2024.11.008_bib53","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/jnnp.2003.026013","article-title":"Meningeal derived cerebrospinal fluid proteins in different forms of dementia: is a meningopathy involved in normal pressure hydrocephalus?","volume":"75","author":"Brettschneider","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0006-3223(94)90064-7","article-title":"Neuropeptide Y cerebrospinal fluid levels in patients with normal pressure hydrocephalus syndrome","volume":"36","author":"Catalan","year":"1994","journal-title":"Biol Psychiatr"},{"issue":"2","key":"10.1016\/j.nec.2024.11.008_bib55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/CPJ.0000000000001156","article-title":"CSF biomarkers predict gait outcomes in idiopathic normal pressure hydrocephalus","volume":"12","author":"Darrow","year":"2022","journal-title":"Neurol Clin Pract"},{"issue":"15","key":"10.1016\/j.nec.2024.11.008_bib56","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.0b013e31828c2fda","article-title":"Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers","volume":"80","author":"Jeppsson","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JAD-142622","article-title":"Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer\u2019s disease","volume":"45","author":"Jingami","year":"2015","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib58","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3233\/JAD-160848","article-title":"Decreased expression of hsa-miR-4274 in cerebrospinal fluid of normal pressure hydrocephalus mimics with parkinsonian syndromes","volume":"56","author":"Jurjevi\u0107","year":"2017","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-024-00561-5","article-title":"Molecular signatures of normal pressure hydrocephalus: a large-scale proteomic analysis of cerebrospinal fluid","volume":"21","author":"Kamalian","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.nec.2024.11.008_bib60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2006.11.039","article-title":"Expression of TGF-betas and TGF-beta type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus","volume":"413","author":"Li","year":"2007","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12987-021-00289-6","article-title":"Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus","volume":"18","author":"Lolansen","year":"2021","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12987-023-00472-x","article-title":"Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases","volume":"20","author":"Braun","year":"2023","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"10.1016\/j.nec.2024.11.008_bib63","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clineuro.2008.10.001","article-title":"CSF neurotransmitter metabolites and neuropsychiatric symptomatology in patients with normal pressure hydrocephalus","volume":"111","author":"Markianos","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"issue":"9","key":"10.1016\/j.nec.2024.11.008_bib64","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1136\/jnnp.74.9.1272","article-title":"CSF galanin and cognition after shunt surgery in normal pressure hydrocephalus","volume":"74","author":"Matar\u00f3","year":"2003","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-49440-3","article-title":"Mass spectrometry in cerebrospinal fluid uncovers association of glycolysis biomarkers with Alzheimer\u2019s disease in a large clinical sample","volume":"13","author":"de Geus","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.nec.2024.11.008_bib66","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00701-011-0963-z","article-title":"Leucine-rich \u03b1-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus","volume":"153","author":"Nakajima","year":"2011","journal-title":"Acta Neurochir"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5603\/pjnns.98212","article-title":"Neuronal pentraxin 2 correlates with neurodegeneration but not cognition in idiopathic normal pressure hydrocephalus (iNPH)","volume":"58","author":"Patel","year":"2024","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10072-006-0562-6","article-title":"Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer\u2019s disease patients","volume":"27","author":"Rota","year":"2006","journal-title":"Neurol Sci"},{"issue":"3","key":"10.1016\/j.nec.2024.11.008_bib69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10072-009-0181-0","article-title":"CSF proteomic analysis in patients with normal pressure hydrocephalus selected for the shunt: CSF biomarkers of response to surgical treatment","volume":"31","author":"Scollato","year":"2010","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.nec.2024.11.008_bib70","first-page":"1","article-title":"Elevated CSF LRG and decreased alzheimer\u2019s disease biomarkers in idiopathic normal pressure hydrocephalus","volume":"10","author":"Vanninen","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.nec.2024.11.008_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-023-00440-5","article-title":"Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus","volume":"20","author":"Weiner","year":"2023","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"10.1016\/j.nec.2024.11.008_bib72","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3233\/JAD-221180","article-title":"Increased cerebrospinal fluid levels of soluble triggering receptor expressed on myeloid cells 2 and Chitinase-3-like protein 1 in idiopathic normal-pressure hydrocephalus","volume":"93","author":"Yang","year":"2023","journal-title":"J\u00a0Alzheimers Dis"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368024000950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368024000950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:38:15Z","timestamp":1762353495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368024000950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1042368024000950"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2024.11.008","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and Prognostic Biomarkers of Idiopathic Normal Pressure Hydrocephalus in Cerebrospinal Fluid and Blood","name":"articletitle","label":"Article Title"},{"value":"Neurosurgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nec.2024.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}